Metaprolate XR 12.5

Metoprolol Succinate may be prescribed during pregnancy when a healthcare professional determines that the benefits outweigh potential risks. Inform your doctor if you are pregnant or planning pregnancy so appropriate treatment and monitoring can be arranged.

Metoprolol Succinate passes into breast milk in small amounts and is generally considered compatible with breastfeeding in many situations. Consult your doctor before use, particularly if your infant is premature or has health concerns requiring additional monitoring.

Metoprolol Succinate may cause dizziness, tiredness, or lightheadedness, particularly when starting treatment or increasing the dose. Avoid driving or operating machinery if these symptoms affect your alertness. Resume these activities only when you feel well and can do so safely.

Patients with kidney disease should inform their doctor before taking Metoprolol Succinate. Kidney impairment does not usually require routine dosage adjustment, but individual assessment remains important to ensure safe treatment, especially when other medical conditions or medicines are involved.

Patients with liver disease should consult their doctor before taking Metoprolol Succinate. Liver impairment may slow the breakdown of the medicine, potentially increasing its effects. Your healthcare professional may recommend a lower dose or closer monitoring when appropriate.